Form 4: CEL SCI CSO Boosts Stake with Share Purchase

CEL SCI's Chief Scientific Officer, Eyal Talor, acquired 747 shares of common stock at $3.21 per share, increasing direct ownership to 7,011 shares.

Summary

• Eyal Talor, Chief Scientific Officer of CEL SCI CORP (CVM), acquired 747 shares of common stock.
• The transaction occurred on March 31, 2026, at a price of $3.21 per share.
• Following this acquisition, Eyal Talor directly beneficially owns a total of 7,011 shares of CEL SCI common stock.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive signal, as an insider's decision to purchase company stock typically reflects confidence in the company's prospects and current valuation.

Positives

• The Chief Scientific Officer's acquisition of additional shares signals confidence in the company's future performance and valuation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying, such as this transaction, is often interpreted by the market as a positive signal, indicating that management believes the company's stock is undervalued or expects positive developments.

Comparison to Industry Standards

• Insider buying is generally viewed positively across industries, indicating management's belief in future performance. No specific company or project comparisons are applicable for this type of filing, which reports an individual insider transaction rather than operational results.

Related Party Transactions

• The acquisition of common stock by Eyal Talor, the Chief Scientific Officer, constitutes a related party transaction.

Stakeholder Impact

• Shareholders may interpret this insider purchase as a positive indicator of management's confidence in the company's future, potentially influencing investor sentiment.

Key Dates

Recommendation

The Chief Scientific Officer's acquisition of shares signals confidence in the company's future prospects and valuation, which is generally a positive indicator for investors. While a single transaction, it suggests an insider believes the stock is a good investment at the current price.

Keywords

CVM, CEL SCI, Insider Trading, Form 4, Stock Acquisition, Eyal Talor, Chief Scientific Officer, Equity Purchase